This content is only available within our institutional offering.
06 Sep 2017
Interim results Traumakine Phase III timing
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Interim results Traumakine Phase III timing
Faron Pharmaceuticals Oy (FARN:LON) | 0 0 (-0.4%) | Mkt Cap: 84.6m
- Published:
06 Sep 2017 -
Author:
Dr Julie Simmonds -
Pages:
5